Advertisement
Screener

Regenicin, Inc. Accrued Liabilities, Current

Regenicin, Inc. Accrued Liabilities, Current

Regenicin, Inc. had Accrued Liabilities, Current of $281.74 thousand as of 2023-03-31, per its 10-Q filed 2023-05-15.

Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current › Accrued Liabilities, Current

us-gaap:AccruedLiabilitiesCurrent · last filed 2023-05-15

  • 2023-03-31: Accrued Liabilities, Current $281.74K.
  • 2022-12-31: Accrued Liabilities, Current $267.66K.
  • 2022-09-30: Accrued Liabilities, Current $254.59K.
  • 2022-06-30: Accrued Liabilities, Current $262.32K.
Period endAccrued Liabilities, CurrentAccrued Liabilities, Current as first filed
2023-03-31$281.74K
10-Q · filed 2023-05-15
2022-12-31$267.66K
10-Q · filed 2023-02-13
2022-09-30$254.59K
10-Q · filed 2023-05-15
2022-06-30$262.32K
10-Q · filed 2022-08-12
2022-03-31$255.92K
10-Q · filed 2022-05-23
2021-12-31$243.16K
10-Q/A · filed 2022-03-25
2021-09-30$254.59K
10-K · filed 2023-01-13
$441.39K
10-K · filed 2022-01-13
2021-06-30$269.14K
10-Q · filed 2021-08-23
2021-03-31$251.14K
10-Q · filed 2021-05-17
2020-12-31$182.72K
10-Q · filed 2021-02-22
2020-09-30$234.89K
10-K · filed 2023-01-13
$174.44K
10-K · filed 2021-01-13
2020-06-30$309.55K
10-Q · filed 2020-08-19
2019-12-31$174.44K
10-Q · filed 2021-02-22
2019-09-30$271.13K
10-K · filed 2021-01-13